Canine Blood Test
Veterinary Diagnostics Institute Inc. (VDxI) announces the launch of Canine CardioCare, the first canine-specific N-terminal brain natriuretic peptide (NT-proBNP) blood test to detect heart disease in dogs.
Veterinary Diagnostics Institute Inc. (VDxI) announces the launch of Canine CardioCare, the first canine-specific N-terminal brain natriuretic peptide (NT-proBNP) blood test to detect heart disease in dogs.
Testing for NT-proBNP is recommended for all dogs age 6 and older as well as high-risk breeds, the company says.
In an independent clinical study, NT-proBNP was shown to be elevated by more than 10-fold in dogs with heart disease.
NT-proBNP is the preferred biomarker over BNP, the active hormone, as it has higher stability and hence higher values in disease states, according to the company.
For fastest response, visit
